SCHEMBL8553682

SCHEMBL8553682

CCCC(=O)N(Cc1ccc(-c2ccccc2-c2nc(=O)s[nH]2)cc1)c1nn(C)cc1C(=O)O

nearest known ligand 0.49

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
LTB4R2 Q9NPC1 19/20 0.49
AGTR1 P30556 2/20 0.49
AGTR2 P50052 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8551369 0.91 LTB4R2 (0.41) LTB4R2AGTR1AGTR2
SCHEMBL8553684 0.86 AGTR1 (0.65) AGTR1AGTR2
SCHEMBL8548489 0.85 LTB4R2 (0.49) LTB4R2AGTR1AGTR2
SCHEMBL8552462 0.82 LTB4R2 (0.49) LTB4R2AGTR1
SCHEMBL8551398 0.79 AGTR1 (0.53) AGTR1AGTR2
SCHEMBL8550196 0.78 LTB4R2 (0.53) LTB4R2AGTR1
SCHEMBL8551839 0.76 LTB4R2 (0.42) LTB4R2AGTR1AGTR2
SCHEMBL8553680 0.76 AGTR1 (0.37) AGTR1AGTR2
SCHEMBL8553533 0.75 LTB4R2 (0.45) LTB4R2AGTR1AGTR2
SCHEMBL6623911 0.73 AGTR1 (0.65) AGTR1AGTR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0588299-B1 1,2,4-Oxadiazolyl- or 1,2,4-thiadiazolyl-biphenyl derivatives as angiotensin II antagonists TAKEDA CHEMICAL INDUSTRIES LTD (JP) 1998-07-01 EP disclosed
EP-0829479-A1 Heterocyclic compounds and their use as angiotensin II antagonists TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1998-03-18 EP disclosed
US-5500427-A ANGIOTENSIN II ANTAGONISTS TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1996-03-19 US disclosed
EP-0588299-A2 1,2,4-Oxadiazolyl- or 1,2,4-thiadiazolyl-biphenyl derivatives as angiotensin II antagonists TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1994-03-23 EP disclosed